Skip to main content

Published locations for FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD

User login

  • Reset your password
  • /content/fda-approves-uplizna-treatment-anti-aqp4-antibody-positive-nmosd
  • /neurologyreviews/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti-aqp4-antibody
  • /multiplesclerosishub/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti-aqp4
  • /neurology/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti-aqp4-antibody
  • /neurology/msresourcecenter/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti
  • /breast-cancer-icymi/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti-aqp4
  • /b-cell-lymphoma-icymi/article/223920/multiple-sclerosis/fda-approves-uplizna-treatment-anti-aqp4